title: Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.
authors.affiliation: Dana-Farber Cancer Institute, Boston, Mass.
authors.forename: F P
authors.initials: FP
authors.lastname: Li
authors.forename: J E
authors.initials: JE
authors.lastname: Garber
authors.forename: S H
authors.initials: SH
authors.lastname: Friend
authors.forename: L C
authors.initials: LC
authors.lastname: Strong
authors.forename: A F
authors.initials: AF
authors.lastname: Patenaude
authors.forename: E T
authors.initials: ET
authors.lastname: Juengst
authors.forename: P R
authors.initials: PR
authors.lastname: Reilly
authors.forename: P
authors.initials: P
authors.lastname: Correa
authors.forename: J F
authors.initials: JF
authors.lastname: Fraumeni
mesh_terms: D026724:Ethical Review; D016158:Genes, p53; D030342:Genetic Diseases, Inborn; D006801:Humans; D016864:Li-Fraumeni Syndrome / Q000235:genetics*; D033242:Minors; D009154:Mutation; D009369:Neoplasms / Q000209:etiology / Q000235:genetics*; D033282:Parental Consent; D010865:Pilot Projects; D018570:Risk Assessment